Original Research
Published on 04 Nov 2025
Metabolic subtyping reveals PDIK1L as a dual-functional regulator of progression and PARP inhibitor sensitivity in prostate cancer
in Cancer Cell Biology
Frontiers in Cell and Developmental Biology
doi 10.3389/fcell.2025.1674844
- 1,855 views
